SiRes 2025
Conference Management System
Main Site
Submission Guide
Register
Login
User List | Statistics
Abstract List | Statistics
Poster List
Paper List
Reviewer List
Presentation Video
Online Q&A Forum
Ifory System
:: Abstract ::

<< back

Alpha-amylase Inhibitory Activity of Sembung Stem Extract (Blumea balsamifera L.) as an Antidiabetic Agent
Ratih Aryani, Umi Yuniarni, Bertha Rusdi, Tarisa Perolin

Universitas Islam Bandung


Abstract

Diabetes mellitus is a degenerative disease caused by chronic metabolic disorders, characterized by hyperglycemia. This condition is typically triggered by decreased tissue sensitivity to insulin, which can lead to various progressive and multifactorial systemic complications. One strategy to control hyperglycemia is to inhibit carbohydrate-hydrolyzing enzymes, such as alpha-amylase, thereby managing postprandial blood glucose spikes. The stem of sembung (Blumea balsamifera L.) is known to contain secondary metabolites with potential antidiabetic properties. This study aimed to determine the alpha-amylase inhibitory activity of sembung stem extract using the DNS (3,5-dinitrosalicylic acid) method. The extract was obtained through maceration using 96% ethanol as the solvent, followed by in vitro evaluation of alpha-amylase inhibitory activity by determining the IC&#8325-&#8320- value, with acarbose used as the reference standard. The results showed that the ethanolic extract of sembung stem had an IC50 value of 232.68 ppm (weak category), while acarbose exhibited an IC50 value of 4.33 ppm (very strong category). Although its activity was lower than acarbose, the sembung stem extract demonstrated potential as an antidiabetic agent through alpha-amylase inhibition.

Keywords: Sembung, Blumea balsamifera, antidiabetic activity, alpha-amylase, IC50

Topic: Chemistry

Plain Format | Corresponding Author (Ratih Aryani)

Share Link

Share your abstract link to your social media or profile page

SiRes 2025 - Conference Management System

Powered By Konfrenzi Ultimate 1.832M-Build8 © 2007-2026 All Rights Reserved